Anna Boroń-Kaczmarska

Prof. Dr. Anna Boroń-Kaczmarska


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
DPDamian Piotrowski
Damian Piotrowski
ASAnna Sączewska-Piotrowska
Anna Sączewska-Piotrowska
JJJerzy Jaroszewicz
Jerzy Jaroszewicz
ABAnna Boroń-Kaczmarska
Anna Boroń-Kaczmarska
Background and aim: The aim of this study was to assess the diagnostic performance of new morphology-related indices and Child–Turcotte–Pugh (CTP) and Model for End-Stage Liver Disease (MELD) scores during hospitalization in predicting the onset of bacterial infection in patients with liver cirrhosis. Material and methods: A total of 171 patients (56.9% males; median age 59 years; total number of hospitalizations 209) with liver cirrhosis were included in this observational study. The diagnosis of cirrhosis was made on the basis of clinical, biochemical, ultrasonic, histological, and endoscopic findings. The neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), modified aspartate aminotransferase-to-platelet ratio index (APRI), aspartate aminotransferase-to-alanine aminotransferase ratio (AAR), Fibrosis-4 index (FIB-4), platelet-to-lymphocyte ratio (PLR), neutrophil-to-monocyte ratio (NMR), and CTP and MELD scores were calculated for the cases of patients with cirrhosis. Results: Bacterial infection was diagnosed in 60 of the 209 (28.7%) hospitalizations of patients with cirrhosis. The most common infections were urinary tract infection (UTI), followed by pneumonia and sepsis. The more severe the liver failure, the greater the bacterial infection prevalence and mortality. Patients with decompensated liver cirrhosis were infected more often than subjects with compensated cirrhosis (50.0% vs. 12.9%, p = 0.003). The calculated MELD score, CTP, NLR, LMR, AAR, monocyte count, and C-reactive protein (CRP) concentration were also related to the bacterial infection prevalence, and mortality areas under the curve (AUC) were 0.629, 0.687, 0.606, 0.715, 0.610, 0.648, and 0.685, respectively. The combined model with two variables (LMR and CTP) had the best AUC of 0.757. The most common bacteria isolated from patients with UTI were Escherichia coli, Enterococcus faecalis, and Klebsiella pneumonia. Gram-negative bacteria were also responsible for spontaneous bacterial peritonitis (SBP), and together with gram-positive streptococci and staphylococci, these microorganisms were isolated from blood cultures of patients with sepsis. Significant differences were found between CTP classification, MELD score, NLR, LMR, AAR, CRP, and PLR in patients with cirrhosis with, or without, bacterial infection. Conclusions: Bacterial infection prevalence is relatively high in patients with liver cirrhosis. Although all analyzed scores, including the LMR, NLR, aspartate aminotransferase (AST)/alanine aminotransferase (ALT), CRP, CTP, and MELD, allowed the prediction of bacterial occurrence, the LMR had the highest clinical utility, according to the area under the curve (AUC) and odds ratio (OR).

1 June 2004 in Infection
Verified
Journal Article
Closed access
PDF file
ABAnna Boroń-Kaczmarska
Anna Boroń-Kaczmarska
MRMieczyslaw Radkowski
Mieczyslaw Radkowski
MWM. Wawrzynowicz-Syczewska
M. Wawrzynowicz-Syczewska
JKJ. Kubicka
J. Kubicka
ZLZ. Lewandowski
Z. Lewandowski

21 December 2012 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MPMiłosz Parczewski
Miłosz Parczewski
DBDorota Bander
Dorota Bander
AUAnna Urbańska
Anna Urbańska
ABAnna Boroń-Kaczmarska
Anna Boroń-Kaczmarska
HIV integrase inhibitor use is limited by low genetic barrier to resistance and possible cross-resistance among representatives of this class of antiretrovirals. The aim of this study was to analyse integrase sequence variability among antiretroviral treatment naive and experienced patients with no prior integrase inhibitor (InI) exposure and investigate development of the InI drug resistance mutations following the virologic failure of the raltegravir containing regimen.

6 September 2001
Verified
Journal Article
Closed access
ABAnna Boroń-Kaczmarska
Anna Boroń-Kaczmarska
MWM Wawrzynowicz-Syczewska
M Wawrzynowicz-Syczewska
ABA Boroń-Kaczmarska
A Boroń-Kaczmarska
ZSZ Sych
Z Sych

4 July 2001
Verified
Journal Article
Closed access
ABAnna Boroń-Kaczmarska
Anna Boroń-Kaczmarska